Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
HDKbF/
*H122njH+T
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© _U0f=m
M;NX:mX9
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© C?Ucu]cW
nm+s{
1.Co-stimulators (or co-stimulating molecules) .2pK.$.
oE~RySX
2.NK-kB \1`O_DF~o
@6d[=!9
3.Immunoglobulin superfamily H[UlY?&+
RyN s6
4.antigen-presenting cell (APC) DJ%PWlK5
&?vgP!d&M
5.death domain 6Iw\c
9
akH
6.CCR and CXCR {|\.i
KF/-wZ"
1s
7.Lectin (or mitogen) +O5hH8<&b
Wvqhl
'J
8.Clusters of differentiation, CD) b[7]F
rs.M]8a2{&
9.B7 family \Roz$t-R|f
MfQ!6zE
10.Cytotoxic T lymphocyte, CTL) ipI
LG4
}75e:w[
11.IL-15 and IL-15 receptor (IL-15R) 2"5v[,$1H
-^57oU
12.MHC restriction bF(f*u
2m[<]$
13.Affinity-chromatography m`_ONm'T&
:@)>r9N
14.Cyctosprin A, CsA ]7mt[2Cd
_y>~
yZx
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) _y3Xb`0a
Z<4AL\l 98
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© f9\X>zzB2|
\15nSB
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 RGU\h[
4H-'Dr=G
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ QwJyY{O`
9E
6R0D}
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ h*Pc=/p
uH-)y,2&
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© h=%_Ao<x
+'@Dz9:>
ÃâÒßѧרҵ£º !3v1bGk
xjUtl
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ +H2-ZXr
XGMiW0j0B
Ïû»¯ÄÚ¿Æ£º %!L9)(}"
nJLFfXWx
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ \B
7tX
_Y[bMuUb=
ѪҺ²¡Ñ§×¨Òµ£º Yir
[!{
C{bgkzr
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿